GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Imaging Canada Liquidating IMRSQ · USD

Health Care · US listing · 🇺🇸 United States

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

About Imaging Canada Liquidating

Its shares trade under the ticker IMRSQ. It has been listed since 15 May 2008. In the fiscal year to 31 December 2014, it reported revenue of $28.9m and a net loss of $30.4m. At that date it held total assets of $65.5m and shareholders' equity of $11.8m.

IMRIS, Inc. is engaged in the design, manufacture, and market of image guided therapy systems. The company employs 121 full-time employees The company went IPO on 2008-05-15. The firm engaged in the sale of medical imaging devices. The firm's subsidiaries include IDC USA, Inc., IDC Europe Inc. and 1370509 Alberta Inc.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
15 May 2008
Employees
121

Leadership

Pay as last reported

  • Mr. Hengye GuanChief Executive Officer, Director, since 2020
  • Mr. Xiaoyi YanChief Financial Officer
  • Mr. Rong XueGeneral ManagerC$36,000
  • Mr. Lebin WuDirector
  • Mrs. Charmaine CheungIndependent Director
  • Dr. Paul LinIndependent Director, since 2013C$60,000
  • Mr. Tim SeungIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • IMRIS, Inc. has 121 full-time employees supporting its medical imaging device business.
  • IMRIS, Inc. operates subsidiaries in USA, Europe, and Alberta for global market reach.
  • IMRIS, Inc. successfully completed an IPO on May 15, 2008, securing capital.

Weaknesses

  • IMRIS, Inc. faces challenges with its liquidating status as Imaging Canada Liquidating Corp.
  • IMRIS, Inc. has limited market presence in the Health Care sector compared to competitors.
  • IMRIS, Inc. relies on a single business model for image guided therapy systems.

Opportunities

  • IMRIS, Inc. can expand its medical imaging device sales in the North American market.
  • IMRIS, Inc. has potential to grow in the European market through IDC Europe Inc.
  • IMRIS, Inc. can leverage its subsidiaries to enter new geographic segments.

Threats

  • IMRIS, Inc. faces competition from established medical imaging device manufacturers.
  • IMRIS, Inc. must navigate regulatory changes in the Health Care industry.
  • IMRIS, Inc. is vulnerable to economic downturns affecting healthcare spending.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.